These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 26259581)

  • 21. Association of cardiovascular magnetic resonance-derived circumferential strain parameters with the risk of ventricular arrhythmia and all-cause mortality in patients with prior myocardial infarction and primary prevention implantable cardioverter defibrillator.
    Paiman EHM; Androulakis AFA; Shahzad R; Tao Q; Zeppenfeld K; Lamb HJ; van der Geest RJ
    J Cardiovasc Magn Reson; 2019 May; 21(1):28. PubMed ID: 31096987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circadian variation of ventricular arrhythmia recurrences after cardioverter-defibrillator implantation in patients with healed myocardial infarcts.
    Mallavarapu C; Pancholy S; Schwartzman D; Callans DJ; Heo J; Gottlieb CD; Marchlinski FE
    Am J Cardiol; 1995 Jun; 75(16):1140-4. PubMed ID: 7762501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy.
    Piers SR; Everaerts K; van der Geest RJ; Hazebroek MR; Siebelink HM; Pison LA; Schalij MJ; Bekkers SC; Heymans S; Zeppenfeld K
    Heart Rhythm; 2015 Oct; 12(10):2106-14. PubMed ID: 26004942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lifelong arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy: distribution of events and impact of periodical reassessment.
    Cappelletto C; Stolfo D; De Luca A; Pinamonti B; Barbati G; Pivetta A; Gobbo M; Brun F; Merlo M; Sinagra G
    Europace; 2018 Jun; 20(FI1):f20-f29. PubMed ID: 28633348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular Magnetic Resonance to Predict Appropriate Implantable Cardioverter Defibrillator Therapy in Ischemic and Nonischemic Cardiomyopathy Patients Using Late Gadolinium Enhancement Border Zone: Comparison of Four Analysis Methods.
    Jablonowski R; Chaudhry U; van der Pals J; Engblom H; Arheden H; Heiberg E; Wu KC; Borgquist R; Carlsson M
    Circ Cardiovasc Imaging; 2017 Sep; 10(9):. PubMed ID: 28838961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronary artery reperfusion for ST elevation myocardial infarction is associated with shorter cycle length ventricular tachycardia and fewer spontaneous arrhythmias.
    Nalliah CJ; Zaman S; Narayan A; Sullivan J; Kovoor P
    Europace; 2014 Jul; 16(7):1053-60. PubMed ID: 24158256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heart rate variability density analysis (Dyx) for identification of appropriate implantable cardioverter defibrillator recipients among elderly patients with acute myocardial infarction and left ventricular systolic dysfunction.
    Jørgensen RM; Levitan J; Halevi Z; Puzanov N; Abildstrøm SZ; Messier MD; Huikuri HV; Haarbo J; Thomsen PE; Jons C;
    Europace; 2015 Dec; 17(12):1848-54. PubMed ID: 25755288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanical dispersion assessed by myocardial strain in patients after myocardial infarction for risk prediction of ventricular arrhythmia.
    Haugaa KH; Smedsrud MK; Steen T; Kongsgaard E; Loennechen JP; Skjaerpe T; Voigt JU; Willems R; Smith G; Smiseth OA; Amlie JP; Edvardsen T
    JACC Cardiovasc Imaging; 2010 Mar; 3(3):247-56. PubMed ID: 20223421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy.
    Perazzolo Marra M; De Lazzari M; Zorzi A; Migliore F; Zilio F; Calore C; Vettor G; Tona F; Tarantini G; Cacciavillani L; Corbetti F; Giorgi B; Miotto D; Thiene G; Basso C; Iliceto S; Corrado D
    Heart Rhythm; 2014 May; 11(5):856-63. PubMed ID: 24440822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy.
    McLELLAN AJ; Ellims AH; Prabhu S; Voskoboinik A; Iles LM; Hare JL; Kaye DM; Macciocca I; Mariani JA; Kalman JM; Taylor AJ; Kistler PM
    J Cardiovasc Electrophysiol; 2016 May; 27(5):571-80. PubMed ID: 26840595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Competing risks of monomorphic vs. non-monomorphic ventricular arrhythmias in primary prevention implantable cardioverter-defibrillator recipients: Global Electrical Heterogeneity and Clinical Outcomes (GEHCO) study.
    Tereshchenko LG; Waks JW; Tompkins C; Rogers AJ; Ehdaie A; Henrikson CA; Dalouk K; Raitt M; Kewalramani S; Kattan MW; Santangeli P; Wilkoff BW; Kapadia SR; Narayan SM; Chugh SS
    Europace; 2024 Jun; 26(6):. PubMed ID: 38703375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term arrhythmia-free survival in patients with severe left ventricular dysfunction and no inducible ventricular tachycardia after myocardial infarction.
    Zaman S; Narayan A; Thiagalingam A; Sivagangabalan G; Thomas S; Ross DL; Kovoor P
    Circulation; 2014 Feb; 129(8):848-54. PubMed ID: 24381209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can QRS scoring predict left ventricular scar and clinical outcomes?
    Rosengarten JA; Scott PA; Chiu OK; Shambrook JS; Curzen NP; Morgan JM
    Europace; 2013 Jul; 15(7):1034-41. PubMed ID: 23493411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of repeat programmed ventricular stimulation at electrophysiology study for arrhythmia prediction after acute myocardial infarction.
    Zaman S; Narayan A; Thiagalingam A; Sivagangabalan G; Thomas S; Ross DL; Kovoor P
    Pacing Clin Electrophysiol; 2014 Jul; 37(7):795-802. PubMed ID: 24666010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sudden Cardiac Death Substrate Imaged by Magnetic Resonance Imaging: From Investigational Tool to Clinical Applications.
    Wu KC
    Circ Cardiovasc Imaging; 2017 Jul; 10(7):. PubMed ID: 28637807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wearable Cardioverter-Defibrillators following Cardiac Surgery-A Single-Center Experience.
    Heimeshoff J; Merz C; Ricklefs M; Kirchhoff F; Haverich A; Bara C; Kühn C
    Thorac Cardiovasc Surg; 2019 Mar; 67(2):92-97. PubMed ID: 29925094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.
    Epstein AE; Abraham WT; Bianco NR; Kern KB; Mirro M; Rao SV; Rhee EK; Solomon SD; Szymkiewicz SJ
    J Am Coll Cardiol; 2013 Nov; 62(21):2000-2007. PubMed ID: 23916930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart failure.
    Lin LY; Su MY; Chen JJ; Lai LP; Hwang JJ; Tseng CD; Chen YS; Yu HY; Tseng WY; Lin JL
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1152-9. PubMed ID: 24229767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-invasive imaging to identify susceptibility for ventricular arrhythmias in ischaemic left ventricular dysfunction.
    Rijnierse MT; Allaart CP; de Haan S; Harms HJ; Huisman MC; Beek AM; Lammertsma AA; van Rossum AC; Knaapen P
    Heart; 2016 Jun; 102(11):832-40. PubMed ID: 26843532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of inducible very fast ventricular tachycardia (cycle length 200-230 ms) after early reperfusion for ST-segment-elevation myocardial infarction.
    Zaman S; Kumar S; Sullivan J; Narayan A; Thiagalingam A; Ross DL; Kovoor P
    Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):884-90. PubMed ID: 23995117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.